A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT02407236 · COMPLETED
Trial details
- NCT number
- NCT02407236
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-10
- Primary completion
- 2018-08-10
- Enrollment
- 961
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.